| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chf Gl Pdt Str Ofcr
1 company
Jenne Kyle is an EVP, Chf Gl Pdt Str Ofcr at Ionis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chf Gl Pdt Str Ofcr | Sale+OE | 4,902 | $75.17 | $368,488.24 | -17.1% | - | - | |
| Mar 10, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chf Gl Pdt Str Ofcr | Sale+OE | 37,277 | $75.85 | $2,827,324.68 | -48.5% | - | - | |
| Apr 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Gl Pdt Str Ofcr | Sale+OE | 3,016 | $28.36 | $85,533.76 | -21.2% | +48.1% | - |